Unknown

Dataset Information

0

Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma.


ABSTRACT: PURPOSE:Merkel cell carcinoma (MCC) is an aggressive cancer with frequent metastasis and death with few effective therapies. Because programmed death ligand-1 (PD-L1) is frequently expressed in MCC, immune checkpoint blockade has been leveraged as treatment for metastatic disease. There is therefore a critical need to understand the relationships between MCPyV status, immune profiles, and patient outcomes. EXPERIMENTAL DESIGN:IHC for CD3, CD8, PD-1, PD-L1, and MCPyV T-antigen (to determine MCPyV status) was performed on 62 primary MCCs with annotated clinical outcomes. Automated image analysis quantified immune cell density (positive cells/mm2) at discrete geographic locations (tumor periphery, center, and hotspot). T-cell receptor sequencing (TCRseq) was performed in a subset of MCCs. RESULTS:No histopathologic variable associated with overall survival (OS) or disease-specific survival (DSS), whereas higher CD3+ (P = 0.004) and CD8+ (P = 0.037) T-cell density at the tumor periphery associated with improved OS. Higher CD8+ T-cell density at the tumor periphery associated with improved DSS (P = 0.049). Stratifying MCCs according to MCPyV status, higher CD3+ (P = 0.026) and CD8+ (P = 0.015) T-cell density at the tumor periphery associated with improved OS for MCPyV+ but not MCPyV- MCC. TCRseq revealed clonal overlap among MCPyV+ samples, suggesting an antigen-specific response against a unifying antigen. CONCLUSIONS:These findings establish the tumor-associated immune infiltrate at the tumor periphery as a robust prognostic indicator in MCC and provide a mechanistic rationale to further examine whether the immune infiltrate at the tumor periphery is relevant as a biomarker for response in ongoing and future checkpoint inhibitor trials in MCC. Clin Cancer Res; 22(22); 5553-63. ©2016 AACR.

SUBMITTER: Feldmeyer L 

PROVIDER: S-EPMC5857157 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Purpose</h4>Merkel cell carcinoma (MCC) is an aggressive cancer with frequent metastasis and death with few effective therapies. Because programmed death ligand-1 (PD-L1) is frequently expressed in MCC, immune checkpoint blockade has been leveraged as treatment for metastatic disease. There is therefore a critical need to understand the relationships between MCPyV status, immune profiles, and patient outcomes.<h4>Experimental design</h4>IHC for CD3, CD8, PD-1, PD-L1, and MCPyV T-antigen (to  ...[more]

Similar Datasets

| S-EPMC3570636 | biostudies-literature
| S-EPMC4080622 | biostudies-literature
| S-EPMC6258401 | biostudies-other
| S-EPMC4850357 | biostudies-literature
| S-EPMC5243985 | biostudies-literature
| S-EPMC7407210 | biostudies-literature
| S-EPMC5597743 | biostudies-literature
| S-EPMC9331388 | biostudies-literature
| S-EPMC5665072 | biostudies-literature
| S-EPMC6964696 | biostudies-literature